🤯 Picked by our AI, this stock rallied more than Nvidia this month, yielding 94% since MarchSee the stock

AstraZeneca PLC ADR (AZN)

Currency in USD
After Hours

AZN Comments

peace out♥️
thx im maybe a loose but today am not.
stron bullish sentiment. buy in don't miss out
upside channel.... time to buy
see all my view dep 14♥️
See all my view sep 14
Zoom fire rocket share now 70+ in few Days only.
Target 69 this month.
Why would anyone buy this thing...?
did they develop a vaccine that works now or why is thos going up?
why this trash going up?
already breakout guy.
I would await some further drop based on the below article to come in the near future. The company did not perform well with the vaccine and i opened some short positions if my assumptions are correct.
hold long = big victory ✌
Finally it reached $60+.
AZN and MRK: Lynparza approved in China for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer. Support is strong for the 2 stocks.
the Delta virus already in USA, but the CDC covered up the truth. in this next 2 weeks, millions of people will get infected, many states may lockdown again.
Forget about AZN vaccines, they product it at no profit. The Company continues to engage with governments, international organisations and collaborators around the world to ensure broad and equitable access to this well-tolerated and effective vaccine at no profit during the pandemic period.
The company has been doing a great job so far this year, will continue making profit from COVID-19 vaccines and many other drugs.
Good news, AstraZeneca said the EU had lost its legal case, the company will deliver vaccines to EU.
Wow, look at the hug volume, the long awaited $60 to come next week.
the beginning of the end . the train pulls down.
CBC News Canada: As per The National Advisory Committee on Immunization (NACI) in Canada announced, the people who took 1st dose of AstraZenaca, as 2nd dose they will take Pfizer-BioNTech COVID-19 Vaccine, or Moderna. Since early May, all provinces have halted the use of AstraZeneca for first doses.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.